Literature DB >> 30768994

Latent toxoplasmosis aggravates anxiety- and depressive-like behaviour and suggest a role of gene-environment interactions in the behavioural response to the parasite.

Cecilie Bay-Richter1, Eskild Petersen2, Nico Liebenberg3, Betina Elfving3, Gregers Wegener4.   

Abstract

Toxoplasma gondii (TOX) is an intracellular parasite which infects warm-blooded animals including humans. An increasing number of clinical studies now hypothesize that latent toxoplasmosis may be a risk factor for the development of psychiatric disease. For depression, the results have been varied and we speculate that genetic background is important for the response to latent toxoplasmosis. The main objective of this study was to elucidate gene - environment interactions in the behavioural response to TOX infection by use of genetically vulnerable animals (Flinders sensitive line, FSL) compared to control animals (Flinders resistant line, FRL). Our results show that all infected animals displayed increased anxiety-like behaviour whereas only genetically vulnerable animals (FSL rats) showed depressive-like behaviour as a consequence of the TOX infection. Furthermore, peripheral cytokine expression was increased following the infection, primarily independent of strain. In the given study 14 cytokines, chemokines, metabolic hormones, and growth factors were quantified with the bead-based Luminex200 system, however, only IL-1α expression was affected differently in FSL animals compared to FRL rats. These results suggest that latent TOX infection can induce anxiety-like behaviour independent of genetic background. Intriguingly, we also report that for depressive-like behaviour only the vulnerable rat strain is affected. This could explain the discrepancy in the literature as to whether TOX infection is a risk factor for depressive symptomatology. We propose that the low grade inflammation caused by the chronic infection is related to the development of behavioural symptoms.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; Cytokines; Depression; Gene-environment interactions; Toxoplasma gondii

Mesh:

Year:  2019        PMID: 30768994     DOI: 10.1016/j.bbr.2019.02.018

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

1.  Sulfadiazine Plus Pyrimethamine Therapy Reversed Multiple Behavioral and Neurocognitive Changes in Long-Term Chronic Toxoplasmosis by Reducing Brain Cyst Load and Inflammation-Related Alterations.

Authors:  Barrios Leda Castaño; Andrea Alice Silva; Lina L Hernandez-Velasco; Ana Paula Da Silva Pinheiro; Daniel Gibaldi; José Roberto Mineo; Neide Maria Silva; Joseli Lannes-Vieira
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

Review 2.  Catastrophic consequences: can the feline parasite Toxoplasma gondii prompt the purrfect neuroinflammatory storm following traumatic brain injury?

Authors:  Tamara L Baker; Mujun Sun; Bridgette D Semple; Shiraz Tyebji; Christopher J Tonkin; Richelle Mychasiuk; Sandy R Shultz
Journal:  J Neuroinflammation       Date:  2020-07-25       Impact factor: 8.322

3.  Rosuvastatin revert memory impairment and anxiogenic-like effect in mice infected with the chronic ME-49 strain of Toxoplasma gondii.

Authors:  Fernanda Ferreira Evangelista; Willian Costa-Ferreira; Francini Martini Mantelo; Lucimara Fátima Beletini; Amanda Hinobu de Souza; Priscilla de Laet Sant'Ana; Keller Karla de Lima; Carlos Cesar Crestani; Ana Lúcia Falavigna-Guilherme
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

4.  Chronic Toxoplasma gondii infection and sleep-wake alterations in mice.

Authors:  Damien Dupont; Jian-Sheng Lin; François Peyron; Hideo Akaoka; Martine Wallon
Journal:  CNS Neurosci Ther       Date:  2021-06-04       Impact factor: 5.243

5.  Toxoplasma gondii infection damages the perineuronal nets in a murine model.

Authors:  Ywlliane da Silva Rodrigues Meurer; Ramayana Morais de Medeiros Brito; Valeria Palheta da Silva; Joelma Maria de Araujo Andade; Sarah Sophia Guedes Linhares; Antonio Pereira Junior; Valter Ferreira de Andrade-Neto; Andrea Lima de Sá; Claudio Bruno Silva de Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2020-09-11       Impact factor: 2.743

6.  Seroprevalence, risk factors and impact of Toxoplasma gondii infection on haematological parameters in the Ashanti region of Ghana: a cross-sectional study.

Authors:  Samuel Kekeli Agordzo; Kingsley Badu; Mathew Glover Addo; Christian Kwasi Owusu; Abdul-Hakim Mutala; Austine Tweneboah; Dawood Ackom Abbas; Nana Kwame Ayisi-Boateng
Journal:  AAS Open Res       Date:  2019-11-26

7.  Examining the Relationship between Toxoplasma gondii and Seropositivity and Serointensity and Depression in Adults from the United Kingdom and the United States: A Cross-Sectional Study.

Authors:  Shawn D Gale; Lance D Erickson; Bruce L Brown; Dawson W Hedges
Journal:  Pathogens       Date:  2021-08-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.